Greenlees Sharon
SEC CIK 1926113 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol Myers Squibb | SVP, Ctrl | 689 | — | — | 3 | 2023-05-02 | 2023-05-02 |
Most active insiders at BMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elkins David V | EVP, CFO | — | $1.85M |
| 2 | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| 3 | Holzer Phil M | SVP, Ctrl | — | $33.8K |
| 4 | Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| 5 | Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| 6 | Poole Ahn Amanda | EVP, CHRO | — | — |
| 7 | Gallman Cari | EVP, GC | — | — |
| 8 | Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| 9 | Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| 10 | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
Greenlees Sharon made no open-market trades at BMY in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-03 | 2023-05-02 | BMY | Bristol Myers Squibb | Greenlees Sharon | SVP, Ctrl | M - OptEx | $0.00 | +1,017 | 689 | New | $0 |
| D | 2023-05-03 | 2023-05-02 | BMY | Bristol Myers Squibb | Greenlees Sharon | SVP, Ctrl | J - Other | $0.00 | -62 | 627 | -9% | $0 |
| DM | 2023-05-03 | 2023-05-02 | BMY | Bristol Myers Squibb | Greenlees Sharon | SVP, Ctrl | F - Tax | $68.10 | -346 | 609 | -36% | -$23.6K |
Purchase Sale Sale after option exercise All abbreviations